Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.4.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.4.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.4.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.7.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.7.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.7.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.7.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDK.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.4.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.4.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.4.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.4 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used